Efficacy and safety of adding sotagliflozin, a dual sodium‐glucose co‐transporter ( SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m 2

Benefit:Risk Profile of Dapagliflozin 5 mg in the DEPICT ‐1 and ‐2 Trials in Individuals with Type 1 Diabetes and BMI ≥27 kg/m 2

(2020) Chantal Mathieu et al.   DIABETES OBESITY & METABOLISM

Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies

(2020) Anne L. Peters et al.   DIABETES CARE

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

(2019) Nicole C. Foster et al.   Diabetes Technology & Therapeutics

Overweight and obesity in type 1 diabetes equal those of the general population

(2019) Paul Fellinger et al.   WIENER KLINISCHE WOCHENSCHRIFT

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program

(2019) Thomas Danne et al.   DIABETES CARE

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with Sodium-Glucose Cotransporter (SGLT) Inhibitors

(2019) Thomas Danne et al.   DIABETES CARE

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2019) John B. Buse et al.   DIABETES CARE

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

(2018) John B. Buse et al.   DIABETES CARE

HbA1cand Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study

(2018) Thomas Danne et al.   DIABETES CARE

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

(2017) Satish K. Garg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diabetic ketoacidosis in adults

(2015) Shivani Misra et al.   BMJ-British Medical Journal

Diabetic ketoacidosis in adults

(2015) Shivani Misra et al.   BMJ-British Medical Journal

The Effect of Excess Weight Gain With Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus

(2012) Jonathan Q. Purnell et al.   CIRCULATION